Cargando…

Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review

BACKGROUND: Invasive meningococcal disease (IMD) is uncommon, life-threatening, with many diverse sequelae. The aims were to: 1) comprehensively characterise the sequelae; 2) have a systematic application for sequelae impact in economic evaluation (EE). METHODS: Sequelae categorised as physical/neur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Jing, Begum, Najida, Ruiz-Garcia, Yara, Martinon-Torres, Federico, Bekkat-Berkani, Rafik, Meszaros, Kinga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153861/ https://www.ncbi.nlm.nih.gov/pubmed/35641955 http://dx.doi.org/10.1186/s12889-022-13342-2

Ejemplares similares

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
por: Ruiz Garcia, Yara, et al.
Publicado: (2021)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Correction to: A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
por: Ruiz Garcia, Yara, et al.
Publicado: (2021)

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
por: Martinón-Torres, Federico, et al.
Publicado: (2021)

Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination
por: Soumahoro, Lamine, et al.
Publicado: (2021)

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
por: Ruiz García, Yara, et al.
Publicado: (2021)

02. Beyond B Antigen Coverage: The Potential of the 4CMenB Vaccine for Cross-protection Against Pathogenic Neisseria Infections
por: Garcia, Yara Ruiz, et al.
Publicado: (2021)

Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers
por: Olbrich, Kerstin J., et al.
Publicado: (2018)

Determinants of Meningococcal Vaccination Coverage and Adherence: A Targeted Literature Review Supporting a 16-year-old Healthcare Visit
por: Herrera-Restrepo, Oscar, et al.
Publicado: (2023)

Risk of sequelae after invasive meningococcal disease
por: Voss, Sidsel Skou, et al.
Publicado: (2022)

Influenza: Can we cope better with the unpredictable?
por: Dos Santos, Gaël, et al.
Publicado: (2015)

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review
por: Dos Santos, Gael, et al.
Publicado: (2018)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

7. Two-Dose 4CMenB Vaccination in Adolescents Elicits a Bactericidal Activity against 15 Outbreak-Representative Meningococcal Strains
por: Biolchi, Alessia, et al.
Publicado: (2020)

Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases
por: Gibson, Eddie, et al.
Publicado: (2023)

Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles
por: Gibson, Edward, et al.
Publicado: (2016)

Risk Analysis by Age on the Burden of Meningococcal Disease in Spain
por: Rivero-Calle, Irene, et al.
Publicado: (2022)

Investigating the Role of Mitochondrial Haplogroups in Genetic Predisposition to Meningococcal Disease
por: Salas, Antonio, et al.
Publicado: (2009)

Seasonal influenza vaccination in patients with COPD: a systematic literature review
por: Bekkat-Berkani, Rafik, et al.
Publicado: (2017)

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
por: Ray, Riju, et al.
Publicado: (2017)

2319. Clinical Predictors of Influenza and Hospitalization of Children with Influenza in an Emergent Care Setting
por: Rao, Suchitra, et al.
Publicado: (2019)

Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
por: Scholz, Stefan, et al.
Publicado: (2021)

Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
por: Hagedoorn, Nienke N., et al.
Publicado: (2022)

Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 – a secondary database analysis
por: Guedes, Sandra, et al.
Publicado: (2022)

Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review
por: Gibson, Edward, et al.
Publicado: (2016)

Correction to: Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
por: Scholz, Stefan, et al.
Publicado: (2022)

A database study of clinical and economic burden of invasive meningococcal disease in France
por: Huang, Liping, et al.
Publicado: (2022)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021)

986. Evaluation of Moderate-to-Severe Influenza Disease in Children 6 Months to 8 Years of Age in Colorado
por: Rao, Suchitra, et al.
Publicado: (2018)

Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
por: Martinón-Torres, Federico, et al.
Publicado: (2022)

1145. Meningococcal B Immunization for Adolescents in the Presence of Added Gonorrhea Protection: A Public Health Impact Modelling Study in the United States
por: Kocaata, Zeki, et al.
Publicado: (2023)

Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019)
por: Riccò, Matteo, et al.
Publicado: (2023)

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
por: VÁZQUEZ, J. A., et al.
Publicado: (2016)

Economic Impact of Meningococcal Outbreaks in Brazil and Colombia
por: Constenla, D., et al.
Publicado: (2015)

Economic evaluation of meningococcal vaccines: considerations for the future
por: Christensen, Hannah, et al.
Publicado: (2019)

Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma
por: Gibson, Eddie J, et al.
Publicado: (2020)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico
por: Chacon-Cruz, Enrique, et al.
Publicado: (2022)

Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
por: Bertrand-Gerentes, Isabelle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_84itb61ht7lnch4mlkubtd1b8m